BIO’s new board chair, Ron Cohen, CEO of Acorda Therapeutics, said, “I’m pleased to announce that the BIO Board has approved a change to BIO’s name from the Biotechnology Industry Organization to the Biotechnology Innovation Organization. Still BIO, but now with a name that better expresses the essence of what our member companies represent.”
The new name will be launched in early 2016.
BIO’s president and CEO, Jim Greenwood said, "This is a great move that will help clarify for policymakers and the public the heart of our industry—scientific innovation that will help to heal, feed and fuel the world. Each day, our members use cutting edge science and technology to deliver game-changing products, therapies and cures to improve the human condition.”
